Attention Deficit Hyperactivity Disorder, CNS Stimulants and Sport
- 366 Downloads
Attention deficit hyperactivity disorder (ADHD) affects 1 to 10% of children and is characterised by a persistent pattern of inattention and/or hyperactivity/ impulsivity. Over one-half of children with ADHD have associated conditions, including learning disabilities, conduct disorders, poor coordination, depression, anxiety, obsessive-compulsive disorders and bipolar disorders.
CNS stimulant medication used in the management of ADHD is not permitted for use in competition by the International Olympic Committee (IOC) and this poses a problem for the physicians of patients with ADHD. On the one hand, attention and concentration are improved by stimulant medication and fine motor coordination and balance are improved after methylphenidate administration, but these therapeutic and sport-related benefits are not available to the athlete with ADHD who wishes to compete under IOC rules. It has been suggested that treatment with methylphenidate may be suitable for athletes with ADHD, as cessation of therapy 24 hours before competition is usually adequate to allow drug clearance which should avoid a positive result being returned on drug testing.
More research is needed to establish whether stimulant medication for athletes with ADHD provides an unfair advantage in competition.
KeywordsAttention Deficit Hyperactivity Disorder Adis International Limited Methylphenidate Attention Deficit Hyperactivity Disorder Stimulant Medication
Unable to display preview. Download preview PDF.
- 1.American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994Google Scholar
- 2.Green C. Attention deficit hyperactivity disorder – clearing the confusion. Mod Med (Aust) 1998; 41 (3): 118–26Google Scholar
- 3.Jarman FC. Current approaches to management of attention deficit hyperactivity disorder. Aust Educ Dev Psych 1996; 13 (1): 46–55Google Scholar
- 4.Jarman FC. Management of hyperactivity. Curr Ther 1992; 33 (8): 31–9Google Scholar
- 5.Hazell P. Stimulant treatment for attention deficit hyperactivity disorder. Aust Prescriber 1995; 18 (3): 60–63Google Scholar
- 7.Barkley RA. The north american perspective on attention deficit hyperactivity disorder. Aust Educ Dev Psych 1996; 13 (1): 2–23Google Scholar
- 8.Harvey WJ, Reid G. Motor performance of children with attention- deficit hyperactivity disorder: a preliminary investigation. Adapt Phys Activ Q 1997; 14: 189–202Google Scholar
- 11.Moffitt TE. Juvenile delinquency and attention deficit disorder: boys developmental trajectories from age 3 to age 15. Child Dev 1990; 61: 893–910Google Scholar
- 12.American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed., revised. Washington, DC: American Psychiatric Association, 1987Google Scholar
- 18.Drug evaluation monograph on methylphenidate. Melbourne: Drug Information Centre, Royal Children’s Hospital, 1995Google Scholar
- 19.Drug evaluation monograph on dextroamphetamine. Melbourne: Drug Information Centre, Royal Children’s Hospital, 1995Google Scholar
- 22.Jarman FC. Attention deficit hyperactivity disorder. Aust Paediatr Rev 1995; 5 (1): 1–3Google Scholar
- 30.Bishop P, Beyer R. Attention deficit hyperactivity disorder (ADHD): implications for physical educators. Palaestra 1995; VII (4), 39–46Google Scholar